1. Abu AI, Ajikobi DO, Bachelard H, Cupples WA, S a levsky FC: Responses of mesenteric and renal blood flow dynamics to acute denervation in anesthetized rats; Am J Physiol. 1998, 275 (5), S.R1543-R1552

2. Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cu l tured human monocytes, U937 cells, and in mice; J Immunol. 1989, 143 (11), S.3517-3523

3. Ahrenholz DH, Simmons RL: Fibrin in peritonitis. Beneficial and adverse effects of fibrin in experimental E.coli peritonitis; Surgery. 1980, 88 (1), S.41-47

4. Ammons WS, Kung AH: Recombinant amino terminal fragment of bactericidal/permeability- increasing pr o tein prevents hemodynamic responses to endotoxin; Circ Shock. 1993, 41, S.176-184

5. Anderson RN: Leading Causes for 2000. National Vital Statistics Reports; Hrsg.: CDC Atlanta: Band 50. 2002 S.86

6. Angus Dc, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care; Crit Care Med. 2001, 29 (7), S.1303-1310

7. Angus DC, Wax RS: Epidemiology of sepsis: An update; Crit Care Med. 2001, 29 (7 Suppl), S.S109-S116

8. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM: A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo; Blood. 1987, 69 (1), S.338-340

9. Arndt H, Palitzsch KD, Anderson DC, Rusche J, Grisham MB, Granger DN: Leucocyte-endothelial cell adh e sion in a model of intestinal inflammation; Gut. 1995, 37 (3), S.374-379

10. Arvidsson S, Falt K, Marklund S, Haglund U: Role of free oxygen radicals in the development of gastroi n testinal mucosal damage in Escherichia coli sepsis; Circ Shock. 1985, 18 (4), S.383-393

11. Baatz H, Pleyer U, Thiel HJ, Hammer C: In Vivo Study of Leukocyte-Endothelium Interaction in End o toxin-Induced Uveitis; Invest Ophtalmol Vis Sci. 1995, 36, S.1960-1967

12. Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G: Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats; Infect Immun. 1994, 62 (1), S.99-105

13. Baker JW, Deitch EA, Li M, Berg RD, Specian RD: Hemorrhagic shock induces bacterial translocation from the gut; J Trauma. 1988, 28 (7), S.896-906

14. Bakker J, Zhang H, Depierreux M, van Asbeck S, Vincent J: Effects of N-acetylcysteine in endotoxic shock; Crit Care . 1994, 9 (4), S.236-243

15. Balk RA: Severe sepsis and septic shock. Definitions, epidemology, and clinical manifestations; Crit Care Clin . 2000, 16 (2), S.179-192

16. Barroso AJ, Schmid SG, Zweifach BW, Mathison JC: Polymorphonuclear neutrophil contribution to induced tolera n ce to bacterial lipopolysaccharide; Am Heart Assoc. 1991, 69 (5), S.1196-1206

17. Bauer M: Pathophysiologie der Sepsis; Anaesthesist . 1996, 45 (4), S.312-322

18. Bazil V, Strominger JL : Shedding as a mechanism of down-modulation of CD14 on stimulated human m o nocytes; J Immunol . 1991, 147 (5), S.1567-1574

19. Berg RD: Bacterial translocation from the gastrointestinal tract; Trends Microbiol. 1995, 3 (4), S.149-154

20. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL: Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granuloc y te function; J Clin Invest. 1984, 73, S.1772-1784

21. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ: Efficacy and safety of recombinant human activated protein C for severe sepsis; N Engl J Med . 2001, 344 (10), S.699-709

22. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases; Crit Care Med . 1993, 21 (10 Suppl), S.S423-S435

23. Beutler B, Poltorak A: Sepsis and evolution of the innate immune response; Crit Care Med . 2001, 29 (7 Suppl), S.S2-S6

24. Bevilacqua MP, Stengelin S, Gimbrone-MA J, Seed B: Endothelial leukocyte adhesion molecule 1: An ind u cible receptor for neutrophils related to complement regulatory prot e ins and lectins; Science. 1989, 243 (4895), S.1160-1165

25. Blackwell TS, Christman JW : Sepsis and cytokines: Current status; Br J Anaesth. 1996, 77 (1), S.110-117

26. Bochud PY, Calandra T: Pathogenesis of sepsis: new concepts and implications for fut u re treatment; Brit Med J . 2003, 326 (7383), S.262-266

27. Böhrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Sa e ger HD, Ziegler R, Bierhaus A, Martin E, Nawroth PP: Role of NFkappaB in the mortality of sepsis ; J Clin Invest . 1997, 100 (5), S.972-985

28. Boillot A, Massol J, Maupoil V, Grelier R, Bernard B, Capellier G, Berthelot A, Barale F: Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody ; Crit Care Med. 1997, 25 (3), S.504-511

29. Bone RC: Immunologic dissonance: A continuing evolution in our understanding of the systemic inflamm a tory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS); Ann Intern Med . 1996, 125 (8), S.680-687

30. Bone RC: Let's agree on terminology: Definitions of sepsis; Crit Care Med . 1991, 19 (7) , S.973-976

31. Bone RC: The Pathogenesis of Sepsis; Ann Intern Med . 1991, 115 (6), S.457-469

32. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS; Crit Care Med . 1996, 24 (7), S.1125-1128

33. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation; Crit Care Med. 1996, 24 (1), S.163-172

34. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care M e dicine; Chest. 1992, 101 (6), S.1644-1655

35. Bone RC, Fisher CJ, Jr., Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock; N Engl J Med. 1987, 317 (11), S.653-658

36. Bone RC, Fisher CJ, Jr., Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: A valid clinical entity. Methylprednisolone Severe Sepsis Study Group; Crit Care Med. 1989, 17 (5), S.389-393

37. Bone RC, Grodzin CJ, Balk RA : Sepsis: A new hypothesis for pathogenesis of the disease pr o cess; Chest. 1997, 112 (1), S.235-243

38. Bone RC, Sprung CL, Sibbald WJ : Definitions for sepsis and organ failure; Crit Care Med . 1992, 20 (6), S.724-726

39. Bonfanti R, Furie BC, Furie B, Wagner DD: PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells; Blood . 1989., 73 (5) , S.1109-1112

40. Bouvier C, Guc MO, Furman BL, Parratt JR: Platelet activating factor impairs pressor responses to noradr e naline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity; Circ Shock . 1994, 42 (1), S.14-19

41. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia; Circ Shock. 1985, 17 (4), S.273-284

42. Browne MK, Leslie GB : Animal models of peritonitis; Surg Gynecol Obstet . 1976, 143 (5), S.738-740

43. Bruin KF, von der Mühlen MAM, van Deventer DJH : Endotoxemia and Sepsis: Important Roles for Lipop o lysaccharide Binding Protein and CD14 in Endotoxin Signal Transduction; Sepsis - current perspectives in pathophysiology and therapy.

44. Brunkhorst FM: Definition und Diagnose der Sepsis nach aktuellen Kriterien; Klinikarzt. 2004, 33 (6), S.167-172

45. Brunkhorst FM: Sepsis fordert viel mehr Todesopfer als gedacht; Gesundheitsforschung: Forschung für den Menschen. 2004, 17, S.2-4

46. Buttgereit F, Hiepe F, Burmester GR : Das therapeutische Potential der Lazaroide (21-Aminosteroide); Dtsch med Wschr. 1997, 122 (44), S.1363-1367

47. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW, Endres S, Lonnemann G, Corsetti J, Chernow B, et al.: Circulating interleukin-1 and tumor necrosis factor in septic shock and e x perimental endotoxin fever ; J Infect Dis. 1990, 161 (1), S.79-84

48. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome; Arch Surg . 1986, 121 (2), S.196-208

49. Chen H, Xu D, Qi S, Aboujaoude M, Senechal J, D a loze P: 21-Aminosteroid lipid peroxidation inhibitor U74389G protects the small bowel in the rat against warm and cold ischemia damage ; Transplant Proc. 1994, 26, S.1483-1484

50. Christman JW, Lancaster LH, Blackwell TS : Nuclear factor kappa B: a pivotal role in the systemic infla m matory response syndrome and new target for therapy ; Intensive Care Med . 1998, 24 (11), S.1131-1138

51. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity; Ann Surg. 1992, 215 (4), S.356-62

52. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE : Endotoxemia in human septic shock; Chest . 1991, 99 (1), S.169-175

53. Das UN: Critical advances in septicemia and septic shock ; Crit Care . 2000, 4 (5) , S.290-296

54. De-Carvalho H, Matos JA,Bouskela E, Svensjo E: Vascular permeability increase and plasma volume loss induced by endotoxin was attenuated by hypertonic saline with or without dextran; Shock. 1999, 12 (1), S.75-80

55. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy ; Ann Surg . 1992, 216 (2), S.117-134

56. Deitch EA, Bridges RM: Effect of stress and trauma on bacterial translocation from the gut; J Surg Res. 1987, 42 (5), S.536-542

57. Deitch EA, Ma L, Ma WJ, Grisham MB, Granger DN, Specian RD, Berg RD: Inhibition of endotoxin-induced bacterial translocation in mice; J Clin Invest . 1989, 84 (1), S.36-42

58. Deitch EA, Specian RD, Berg RD: Endotoxin-induced bacterial translocation and mucosal pe r meability: Role of xanthine oxidase, complement activation, and macrophage products ; Crit Care Med. 1991, 19 (6), S.785-791

59. Dellinger RP, Carlet JM, Masur H, Gerlach H, C a landra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM : Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock; Crit Care Med. 2004, 32 (3) , S.858-873

60. Dunzendorfer S, Lee HK, Soldau K, Tobias PS: TLR4 is the signaling but not the lipopolysaccharide uptake receptor; J Immunol . 2004, 173 (2), S.1166-1170

61. Engelberts I, Moller A, Leeuwenberg JF, van der Linden CJ, Buurman WA : Administration of tumor necr o sis factor alpha (TNF alpha) inhibitors after exposure to TNF alpha prevents development of the max i mal biological effect: An argument for clinical treatment with TNF alpha inhibitors; J Surg Res. 1992, 53 (5), S.510-514

62. Engelhardt L: Hrsg.: Medizinische Fakultät Charité der Humboldt-Universität zu Berlin: Einfluss von Methylprednisolon und Tirilazad Mesylat auf immunologische Parameter nach koronarer Bypassoperation - eine placebokontrollierte Studie. Dissertation. 2001

63. Eversole RR, Smith SL, Beuving LJ, Hall ED: Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock; Circ Shock. 1993, 40 (2), S.125-131

64. Fenton MJ, Golenbock DT: LPS-binding proteins and receptors ; J Leukoc Biol. 1998, 64 (1), S.25-32

65. Fiebig E, Ley K, Arfors KE : Rapid leukocyte accumulation by "spontaneous" rolling and adhesion in the exteriorized rabbit mesentery; Int J Microcirc Clin Exp . 1991, 10 (2), S.127-144

66. Fink MP: Leaky gut hypothesis: A historical perspective; Crit Care Med . 1990, 18 (5), S.579-580

67. Fink MP, Antonsson JB, Wang HL, Rothschild HR: Increased intestinal permeability in endotoxic pigs. M e senteric hypoperfusion as an etiologic factor; Arch Surg . 1991, 126 (2), S.211-218

68. Fink MP, Heard SO: Laboratory models of sepsis and septic shock; J Surg Res. 1990, 49 (2), S.186-196

69. Fong Y, Lowry SF: Tumor necrosis factor in the pathophysiology of infection and sepsis; Clin Immunol Immunopathol. 1990, 55 (2), S.157-170

70. Fong Y, Moldawer LL, Shires GT, Lowry SF : The biologic characteristics of cytokines and their implication in surgical injury; Surg Gynecol Obstet. 1990, 170 (4), S.363-378

71. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD: Soluble CD14 partic i pates in the responseof cells to lipopol y saccharide; J Exp Med. 1992, 176 (6), S.1665-1671

72. Friedman G, Berlot G, Kahn RJ, Vincent JL: Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis; Crit Care Med. 1995, 23 (7) , S.1184-1193

73. Fukumura D, Miura S, Kurose I, Higuchi H, Suzuki H, Ebinuma H, Han JY, Watanabe N, Wakabayashi G, Kitajima M, Ishii H: IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage; Dig Dis Sci . 1996, 41 (12), S.2482-2492

74. Ghosh S, Latimer RD, Gray BM, Harwood RJ, Oduro A: Endotoxin-induced organ injury; Crit Care Med . 1993, 21 (2 Suppl) , S.S19-S24

75. Giroir BP: Mediators of septic shock: New approaches for interrupting the endogenous inflammatory casc a de; Crit Care Med. 1993, 21 (5), S.780-789

76. Goode HF, Webster NR: Free radicals and antioxidants in sepsis; Crit Care Med . 1993, 21 (11), S.1770-1776

77. Granger DN, Hollwarth ME, Parks DA: Ischemia-reperfusion injury: Role of oxygen-derived free rad i cals; Acta Physiol Scand . 1986, Suppl 548, S.S47-S63

78. Granger DN, Kubes P: The microcirculation and inflammation: Modulation of leuk o cyte-endothelial cell adhesion ; J Leukoc Biol . 1994, 55 (5) , S.662-675

79. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA: Intestinal blood flow ; Gastroenterology . 1980, 78 (4), S.837-863

80. Gray PW, Corcorran AE, Eddy-RL J, Byers MG, Shows TB: The genes for the lipopolysaccharide binding protein (LBP) and the bactericidal permeability increasing protein (BPI) are encoded in the same region of human chromosome 20; Genomics . 1993, 15 (1), S.188-190

81. Grisham MB, Everse J, Janssen HF: Endotoxemia and neutrophil activation in vivo; Am J Physiol . 1988, 254 (5 Pt 2), S.H1017-H1022

82. Grotz M, Regel G, Bastian L, Weimann A, Neuhoff K, Stalp M, Tscherne H : Der Darm als zentrales Organ in der Entwicklung des Multiorganversagens (MOV) nach schwerem Trauma- Pathophysiol o gie und therapeutische Ansätze; Zentralbl Chir . 1998., 123 (3), S.205-217

83. Grum CM, Fiddian Green RG, Pittenger GL, Grant BJ, Rothman ED, Dantzker DR: Adequacy of tissue ox y genation in intact dog intestine; J Appl Physiol . 1984, 56 (4), S.1065-1069

84. Haglund U, Bulkley GB, Granger DN: On the pathophysiology of intestinal ischemic injury. Clinical review ; Acta Chir Scand . 1987, 153 (5-6), S.321-324

85. Hall ED: Lipid antioxidants in acute central nervous system injury; Ann Emerg Med . 1993, 22 (6), S.1022-1027

86. Hall ED, McCall JM, Means ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarac h noid hemorrhage; Adv Pharmacol . 1994, 28, S.221-268

87. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR: Recognition and plasma clearance of end o toxin by scavenger receptors ; Nature. 1991, 352 (6333), S.342-344

88. Harlan JM: Leukocyte-endothelial interactions ; Blood . 1985, 65 (3), S.513-525

89. Harris NR, Russell JM, Granger DN: Mediators of endotoxin-induced leukocyte adhesion in mese n teric postcapillary venules; Circ Shock . 1994, 43 (4), S.155-160

90. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Go y ert SM : The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. ; J Immunol . 1988, 141 (2), S.547-552

91. Haziot A, Katz I, Rong GW, Lin XY, Silver J, Goyert SM: Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14; Scand J Immunol . 1997, 46 (3), S.242-245

92. Haziot A, Tsuberi BZ, Goyert SM: Neutrophil CD14: Biochemical properties and role in the secr e tion of tumor necrosis factor-alpha in response to lipopolysa c charide ; J Immunol . 1993, 150 (12), S.5556-5565

93. Hein OV, Ohring R, Schilling A, Oellerich M, Ar m strong VW, Kox WJ, Spies C : N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report; Crit Care . 2004, 8 (2), S.R66-R71

94. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P: Endogenous interleukin-10 regulates hem o dynamic parameters, leukocyte- endothelial cell interactions, and microvascular permeability during endotoxemia; Circ Res . 1998, 83 (11), S.1124-1131

95. Hinshaw LB, Emerson TE, Iampietro PF, Brake CM: A comparative study of the hemodynamic actions of histamie and endotoxin; Am J Physiol . 1962, 203 (4), S.600-606

96. Horton JW, Walker PB: Oxygen radicals, lipid peroxidation, and permeability changes after intestinal isch e mia and reperfusion ; J Appl Physiol . 1993, 74 (4), S.1515-1520

97. Hoyert DL, Anderson RN: Age-adjusted death rates: Trend data based on the year 2000 standard population ; Hrsg.: National Vital Statistics Reports: Band 49. 2001 S.1-6

98. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion; Cell . 1992, 69 (1), S.11-25

99. Janeway CA, Travers, P: Immunologie.

100. Janssen GH, Tangelder, Reneman RS: Different effects of anesthetics on spontaneous leukocyte ro l ling in rat skin; Int J Microcirc Clin Exp . 1997, 17 (6), S.305-313

101. Janssen GH, Tangelder GJ, Reneman RS: Spontaneous leukocyte rolling in venules in untraumatized skin of conscious and anesthetized animals; Am J Physiol . 1994, 267 (3 Pt 2), S. H1199-H1204

102. Bunting SA, Wurm FM, Chamow SM, Ashkenazi A: Jin H, Yang R, Marsters SA, Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoa d hesin: comparison with anti-TNF monoclonal antibody ; J Infect Dis . 1994, 170 (5), S.1323-1326

103. Johnston TD, Hampton WW, Fry DE: Septic hemodynamics produced by infusion of endotoxin; Curr Surg . 1989, 46 (2), S.101-103

104. Jungi TW, Sager H, Adler H, Brcic M, Pfister H: Serum factors, cell membrane CD14, and beta2 integrins are not required for activation of bovine macrophages by lipopolysaccharide; Infect Immun . 1997, 65 (9), S.3577-3584

105. Kastner U, Glasl S, Lugauer S, Guggenbichler JP: Sepsis- Neue Erkenntnisse zur Pathophysiologie, Ther a pie und Prävention; Hrsg.: Antibiotika Mon i tor: S.1-20

106. Kayser FH, Bienz KA, Eckert J, Lindenmann J: Allgemeine Bakteriologie, Morphologie und Feinstruktur der Bakterien. In: Wiesmann E, ed. Medizinische Mikrobiologie (Immunologie, Bakteriologie, Mykologie, Virologie, Parasitologie). 7

107. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S: Indocyanine green elimination rate detects hepatocellular dy s function early in septic shock and correlates with survival; Crit Care Med. 2001, 29 (6), S.1159-1163

108. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M : Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide; J Exp Med . 1998, 188 (11), S.2091-2097

109. Kox W, Spies C: Check-up Anästhesiologie.

110. Kox WJ, Volk T, Kox SN, Volk HD: Immunomodulatory therapies in sepsis; Intensive Care Med . 2000, 26 (Suppl 1), S.S124-S128

111. Kretzschmar M: ole oxygen free radials in the pathophysiology of sepsis; Sepsis - current perspectives in pathophysiology and therapy.

112. Kreymann G. WM: Geschichte und Definition der Sepsis - Brauchen wir eine neue Terminologie? Anasth e siol ; Intensivmed Notfallmed Schmerzther . 1996, 31 (1), S.9-14

113. Kubes P, Grisham MB, Barrowman JA, Gaginella T, Granger DN: Leukocyte-induced vascular protein leakage in cat mesentery. ; Am J Physiol . 1991, 261 (6 Pt 2), S.H1872-H1879

114. Kuebler WM, Borges J, Sckell A, Kuhnle GE, Bergh K, Messmer K, Goetz AE: Role of L-selectin in leuk o cyte sequestration in lung capillaries in a rabbit model of endotoxemia ; Am J Respir Crit Care Med . 2000, 161 (1), S.36-43

115. Kuhns DB, Alvord WG, Gallin JI : Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in h u mans; J Infect Dis . 1995, 171 (1), S.145-152

116. Kurose I, Suematsu M, Miura S, Fukumura D, Sekiz u ka E, Nagata H, Oshio C, Tsuchiya M : Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery-attenuating effect of cetraxate; Toxicol Appl Pharmacol . 1993, 120 (1) , S.37-44

117. Küttler T: Pharmakologie und Toxikologie. 16

118. Lehmann C, Georgiew A, Weber M, Birnbaum J, Kox WJ: Reduction in intestinal leukocyte adherence in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G; Intensive Care Med . 2001, 27 (1), S.258-63

119. Lenhartz H: Die septischen Erkrankungen .

120. Lentsch AB, Ward PA: Activation and regulation of NFkappaB during acute inflamm a tion; Clin Chem Lab Med . 1999, 37 (3), S.205-208

121. Ley K: Histamine can induce leukocyte rolling in rat mesenteric ven u les; Am J Physiol . 1994, 267 (3 Pt 2), S.H1017-H1023

122. Ley K: Leukocyte adhesion to vascular endothelium; J Reconstr Microsurg . 1992, 8 (6), S.495-503

123. Ley K, Tedder TF: Leukocyte interactions with vascular endothelium. New i n sights into selectin-mediated attachment and rolling; J Immunol . 1995, 155 (2), S.525-528

124. Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: sampling, selection, and society; Crit Care. 2004, 8 (4), S.222-226

125. Loppnow H: Cytokines: Classification, receptors, mechanisms of action; Internist . 2001, 42 (1) , S.13-4, 17-27

126. Luther B, Burger K, Paul D, Lehmann C, Buchali K: Zur Pathophysiologie der intestinalen Blutzirkulation. Tiere x perimentelle Ergebnisse; Angio . 1990, 12 (5), S.173-184

127. Maejima K, Deitch E, Berg R. : Promotion by burn stress of the translocation of bacteria from the gastroi n testinal tracts of mice; Arch Surg . 1984, 119 (2), S.166-172

128. Maejima K, Deitch EA, Berg RD: Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injury; Infect Immun . 1984, 43 (1), S.6-10

129. Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract. The "undrained abscess" of multiple organ failure; Ann Surg . 1993, 218 (2), S.111-119

130. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000; N Engl J Med . 2003, 348 (16), S.1546-1554

131. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ: Lipopolysacch a ride binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysacchar i de. Implications for cytokine production in normal and injured lungs ; J Clin Invest . 1992, 90 (6), S.2209-2219

132. Massignon D, Lepape A, Bienvenu J, Barbier Y, Bo i leau C, Coeur P: Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state; Haemostasis . 1994, 24 (1), S.36-48

133. Mayrovitz HN: Leukocyte rolling: A prominent feature of venules in intact skin of anesthetized hairless mice; Am J Physiol . 1992, 262 (1 Pt 2), S.H157-H161

134. McKechnie K, Furman BL, Parratt JR: Modification by oxygen free radical scavengers of the metab o lic and cardiovascular effects of endotoxin infusion in consc i ous rats; Circ Shock . 1986, 19 (4), S.429-439

135. Minamiya Y, Abo S, Kitamura M, Izumi K, Kimura Y, Tozawa K, Saito S: Endotoxin-induced hydrogen peroxide production in intact pulmonary circulation of rat; Am J Respir Crit Care Med. 1995, 152 (1), S.348-354

136. Miura S, Tsuzuki Y, Kurose I, Suematsu M, Shigema t su T, Kimura H, Higuchi H, Serizawa H, Yagita H, Okumura K, Granger DN, Ishii H: Endotoxin stimulates lymphocyte-endothelial interactions in rat i n testinal Peyer's patches and villus mucosa; Am J Physiol . 1996, 271 (2 Pt 1), S.G282-G292

137. Moazzam F, Delano FA, Zweifach BW, Schmid-Schoenbein GW: The leukocyte response to fluid stress; Proc Natl Acad Sci USA . 1997, 94 (10), S.5338-5343

138. Moerer O, Schmid A, Hofmann M, Herklotz A, Rei n hart K, Werdan K, Schneider H, Burchardi H: Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient r e cord analysis of resource use; Intensive Care Med . 2002, 28 (10), S.1440-1446

139. Morgan RA, Manning PB, Coran AG, Drongowski RA, Till GO, Ward PD, Oldham KT: Oxygen free rad i cal activity during live E. coli septic shock in the dog ; Circ Shock . 1988, 25 (4), S.319-323

140. Moskopp DWH: Zerebroprotektive Maßnahmen bei Energiekrisen des Gehirns.

141. Mullen PG, Fisher BJ, Walsh CJ, Susskind BM, Le e per-Woodford SK, Jesmok GJ, Fowler AA, Sugerman HJ: Monoclonal antibody to tumor necrosis factor-alpha attenuates plasma interleukin-6 levels in porc i ne gram-negative sepsis; J Surg Res. 1994, 57 (5), S.625-31

142. Nakayama M, Hasegawa N, Oka Y, Lutzke B, McCall JM, Raffin TA: Effects of the lazaroid, tirilazad m e sylate, on sepsis-induced acute lung injury in minipigs; Crit Care Med . 1998, 26 (3), S.538-547

143. Navaratnam RL, Morris SE, Traber DL, Flynn J, Woodson L, Linares H, Herndon DN: Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT); J Trauma . 1990, 30 (9), S.1104-1113

144. Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ: The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis; J Infect Dis . 2002, 185 (10), S.1483-1489

145. Neugebauer E, Rixen D, Raum M, Schafer U: Thirty years of anti-mediator treatment in sepsis and septic shock- what have we learned? ; Langenbecks Arch Surg. 1998, 383 (1), S.26-34

146. Neugebauer EAH: Handbook of Mediators in Septic Shock.

147. Neviere RR, Pitt HM, Piper RD, Sibbald WJ, Potter RF: Microvascular perfusion deficits are not a prer e quisite for m u cosal injury in septic rats; Am J Physiol. 1999, 276 (4 Pt 1), S.G933-G940

148. Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C m i ce; Am J Physiol . 1994, 267 (4 Pt 2), S.H1320-H1328

149. Oka Y, Murata A, Nishijima J, Yasuda T, Hiraoka N, Ohmachi Y, Kitagawa K, Toda H, Tanaka N, et al. : Circulating interleukin 6 as a useful marker for predicting pos t operative complications; Cytokine . 1992, 4 (4), S.298-304

150. Opal SM, Cohen J: Clinical gram-positive sepsis: Does it fundamentally differ from gram-negative bacterial sepsis? ; Crit Care Med. 1999, 27 (8), S.1608-1616

151. Ortolani O, Conti A, De-Gaudio AR, Moraldi E, Ca n tini Q, Novelli G : The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock; Am J Respir Crit Care Med . 2000, 161 (6), S.1907-1911

152. Pena LA, Fuks Z, Kolesnick R : Stress-induced apoptosis and the sphingomyelin pathway; Biochem Pharmacol . 1997, 53 (5), S.615-621

153. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to mu l tiple-system organ failure and mortality; Chest . 1993, 103 (2), S.565-575

154. Powell RJ, Machiedo GW, Rush-BF J, Dikdan GS: Effect of oxygen-free radical scavengers on survival in sepsis; Am Surg . 1991, 57 (2), S.86-88

155. Quezado ZMN, Natanson C, Hoffmann WD: Endotoxin in Septic Shock. In: Reinhart K, Eyrich K, eds. Sepsis - current perspectives in pathophysiology and therapy.

156. Radetsky M: The discovery of penicillin; Pediatr Infect Dis J . 1996, 15 (9), S.811-818

157. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C: N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, random i zed, double-blind study; Crit Care Med . 2000, 28 (12), S.3799-3807

158. Redondo P, Subira ML: N-acetylcysteine inhibits production of tumor necrosis factor alpha and interleukin-1 beta; Arch Intern Med . 1996, 156 (11) , S.1238, 1241

159. Reinhart K : Leitlinie Diagnose und Therapie der Sepsis- Methodenreport; Hrsg.: Deutsche Sepsis-Gesel l schaft e.V.: 2005

160. Reinhart KB, Bloos F : Fortschritte in der Therapie der Sepsis; Deutsches Ärzteblatt. 2003, 100 (31-32), S.2080-2086

161. Revhaug A, Michie HR, Manson JM, Watters JM, Dinarello CA, Wolff SM, Wilmore DW: Inhibition of cyclo-oxygenase attenuates the metabolic respo n se to endotoxin in humans ; Arch Surg . 1988, 123 (2), S.162-170

162. Riede U-N, Schaefer H-E: Allgemeine und spezielle Pathologie. 3

163. Rohr U: Hrsg.: Medizinischen Fakultät Charité der Humboldt-Universität zu Berlin: sCD14, TNF, Interleukin-6, sICAM-1 und sE-Selektin im septischen Geschehen. Dissertation . 1998

164. Roth E, Manhart N, Punz A: Role of antioxidants in Sepsis; Intensivmedizin . 1998, 35 (2) , S.95-105

165. Rychlik R: Sozioökonomische Relevanz der Sepsis in Deutschland; Gesundh Ökon Qual Manag. 2001, 5, S.67-72

166. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MG, Macarthur H, Misko TP: Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intest i nal damage; Br J Pharmacol . 1999, 127 (3), S.685-692

167. Scalia R, Armstead VE, Minchenko AG, Lefer AM: Essential role of P-selectin in the initiation of the i n flammatory response induced by hemorrhage and reinfusion; J Exp Med . 1999, 189 (6), S.931-93

168. Schiller HJ, Reilly PM, Bulkley GB: Tissue perfusion in critical illnesses. Antioxidant therapy; Crit Care Med . 1993, 21, S.92-102

169. Schmidt H: Hrsg.: Ruprecht-Karls-Universität Heidelberg: Tierexperimentelle Untersuchungen zur intestinalen Mikrozirkulation und zum intestinalen Purinstoffwechsel bei Endotoxinämie. Habilitation . 1997

170. Schmidt H, Ebeling D, Bauer H, Bach A, Böhrer H, Gebhard MM, Martin E: Ketamine attenuates endot o xin-induced leukocyte adherence in rat mesenteric venules; Crit Care Med . 1995, 23 (12), S.2008-2014

171. Schmidt H, Schmidt W, Müller T, Böhrer H, Bach A, Gebhard MM, Martin E : Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotox e mia; Surgery . 1997, 121 (3), S.328-334

172. Schmidt H, Schmidt W, Müller T, Böhrer H, Gebhard MM, Martin E : N-acetylcysteine attenuates endot o xin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo; Crit Care Med. 1997, 25 (5), S.858-863

173. Schmidt H, Secchi A, Wellmann R, Bach A, Böhrer H, Gebhard MM, Martin E: Effect of endotoxemia on intestinal villus microcirculation in rats; J Surg Res . 1996, 61 (2), S.521-526

174. Schmidt W, Schmidt H, Bauer H, Gebhard MM, Ma r tin E: Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo; Anesthesiology . 1997, 87 (3) , S.617-624

175. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H: Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances; Intensive Care Med . 1998, 24 (9), S.967-972

176. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H: Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances; Intensive Care Med. 1998, 24 (9): , S.967-972,

177. Schneider J, Friderichs E, Heintze K, Flohe L: Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats; Circ Shock. 1990, 30, S.97-106

178. Schottmüller H: Wesen und Behandlung der Sepsis; Verhandl dt Kongress Inn Med . 1914, 31, S.257-280

179. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ: Stru c ture and function of lipopolysaccharide binding protein ; Science . 1990, 249 (4975), S.1429-1431

180. Schuster HP, Werdan K: Intensivtherapie bei Sepsis und Multiorganversagen . 3

181. Seiffge D, Bissinger T, Kremer E, Laux V, Schleye r bach R: Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation; Inflamm Res . 1995, 44 (7), S.281-286

182. Semrad SD, Rose ML, Adams JL: Effect of tirilazad mesylate (U74006F) on eicosanoid and t u mor necrosis factor generation in healthy and endotoxemic neonatal calves ; Circ Shock . 1993, 40 (4),

183. Shong M, Ro HK, Kim YK, Yoo CJ, Lee JH, Song CU, Cho BY: The cytokines , interleukin-1 beta, inte r leukin-6, and interf e ron-gamma upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyreoid cell line, FRTL-5; Korean J Intern Med . 1994, 9 (2), S.88-92

184. Slade E, Tamber PS, Vincent JL : The Surviving Sepsis Campaign: Raising awareness to reduce mortality; Crit Care . 2003, 7 (1), S.1-2

185. Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L: Does N-acetyl-L-cysteine i n fluence cytokine response during early human septic shock?; Chest . 1998, 113 (6), S.1616-24

186. Spies CD, Reinhart K, Witt I, Meier HA, Hannemann L, Bredle DL, Schaffartzik W: Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospect i ve, randomized, double-blind study; Crit Care Med . 1994, 22 (11), S.1738-1746

187. Springer TA: Adhesion receptors of the immune system; Nature . 1990, 346 (6283), S.425-434

188. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm ; Cell . 1994, 76 (2), S.301-314

189. Steinmetz HT, Herbertz A, Bertram M, Diehl V : Increase in interleukin-6 serum level preceding fever in gran u locytopenia and correlation with death from sepsis; J Infect Dis . 1995, 171 (1), S.225-228

190. Thiel M, Zourelidis C, Peter K: The role of polymorphonuclear neutrophilic leukocytes in the pathogenesis of acute respiratory distress syndrome (ARDS); Anaesthesist . 1996, 45 (2), S.113-130

191. Tonnesen MG: Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium; J Invest Dermatol . 1989, 93 (2 Suppl), S.S53-S58

192. Van Lambalgen AA, Rasker MT, van den Bos GC, Thijs LG: Effects of endotoxemia on systemic plasma loss and hematocrit in rats; Microvasc Res . 1988, 36, S.291-304

193. van Lambalgen AA, van den Bos GC, Thijs LG: Changes in regional plasma extravasation in rats following endotoxin infusion; Microvasc Res . 1987, 34 (1), S.116-132

194. Volk T, Hensel M, Schuster H, Kox WJ : Secretion of MCP-1 and IL-6 by cytokine stimulated product i on of reactive oxygen species in endothelial cells ; Mol Cell Biochem . 2000, 206 (1-2), S.105-112

195. von-Andrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, A r fors KE: In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes; J Clin Invest . 1993, 91 (6), S.2893-2897

196. Warner A, Bencosme A, Healy D, Verme C : Prognostic role of antioxidant enzymes in sepsis: preliminary assessment; Clin Chem . 1995, 41 (6 Pt 1), S.867-871

197. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock - A review of laboratory models and a proposal; J Surg Res . 1980, 29, S.189-200

198. Xu D, Qi L, Guillory D, Cruz N, Berg R, Deitch EA : Mechanisms of endotoxin-induced intestinal injury in a hype r dynamic model of sepsis; J Trauma . 1993, 34 (5), S.676-682

199. Yi ES, Ulich TR: Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microva s cular leakage in postcapillary venules; Am J Pathol . 1992, 140 (3), S.659-663

200. Yuan Y, Fleming BP: A method for isolation and fluorescent labeling of rat neutrophils for intravital micr o vascular studies; Microvasc Res. 1990, 40, S.218-229

201. Zander R: Arterial-intramuscular C02-partial pressure difference (aiDC02); Anasthesiol Intensivmed Notfallmed Schmerzther . 1998, 33 Suppl 2, S.S52-S53

202. Zhang H, Spapen H, Manikis P, Rogiers P, Metz G, Buurman WA, Vincent JL: Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs; Am J Physiol . 1995, 268 (5 Pt 2), S.H1847-H1855

203. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buu r man WA, Vincent JL: Protective effects of N-acetyl-L-cysteine in endotoxemia; Am J Physiol . 1994, 266 (5 Pt 2), S.H1746-H1754

204. Zhang H, Spapen H, Nguyen DN, Rogiers P, Bakker J, Vincent JL: Effects of N-acetyl-L-cysteine on regi o nal blood flow during endotoxic shock; Eur Surg Res . 1995, 27 (5), S.292-300

205. Ziegler E: Lehrbuch der Allgemeinen Pathologie und der pathologischen Anatomie.

206. Ziegler-Heitbrock HW, Ulevitch RJ : CD14: cell surface receptor and differentiation marker; Immunol Today . 1993, 14 (3), S.121-125